This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Thorley-Lawson DA and Gross A (2004) Persistence of the Epstein–Barr virus and the origins of associated lymphomas. N Engl J Med 350: 1328–1337
Preiksaitis JK and Keay S (2001) Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients. Clin Infect Dis 33 (Suppl 1): S38–S46
Opelz G and Dohler B (2004) Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 4: 222–230
Starzl TE et al. (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1: 583–587
Dotti G et al. (2000) Epstein–Barr virus-negative lymphoproliferative disorders in long-term survivors after heart, kidney, and liver transplant. Transplantation 69: 827–833
Acknowledgements
The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Veale, J., Gritsch, H. Lymphoma after kidney transplantation: risk factors and timing of development. Nat Rev Nephrol 2, 422–423 (2006). https://doi.org/10.1038/ncpneph0247
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0247